3D Bioprinting Market Worth USD 5.01 Bn by 2029: Investments, Research & Development, Current Trends, Competitive Analysis, Market Drivers, and Manufacturers
Pune, 6, Dec 2022: Maximize Market research has published a market intelligence and industry analysis report on “3D Bioprinting Market“. The global 3D Bioprinting Market was valued at USD 1.16 billion in 2021, and is expected to be worth USD 5.01 billion by 2029, growing at a CAGR of 20.07% during the forecast period. Market definitions are developed in such a way that they may be compared across nations. The parameters of each definition are rigorously examined at the start of the research process to ensure they fit the demands of both the market and MMR’s clients.
rket, request for methodology here @ https://www.maximizemarketresearch.com/request-sample/3271
3D Bioprinting Market Scope and Research Methodology
The Maximize Market Research Industry reports are based on extensive primary and secondary research that has been condensed, evaluated, and cross-checked before being presented in an uniform and user-friendly format. More than 250,000 industry interviews and consumer surveys are utilised to construct a review of in-house information, which is augmented by research done by industry specialists utilising extremely complicated modelling and forecasting technologies. MMR’s internal databases form the backbone for all industry profiles. MMR also maintains vast in-house databases of news, analyst comments, firm profiles, and macroeconomic and demographic data, allowing MMR’s analysts to give an accurate market picture. Market definitions are created in a way that allows them to be compared across countries. At the commencement of the research process, the criteria of each definition are thoroughly analysed to ensure they meet the needs of both the market and MMR’s clients.
3D Bioprinting Market Overview
Innovative drug screening and development platforms have led to advancements in 3D bioprinting technology, allowing for the development of several all-inclusive high throughputs and customizable organ-on-chip type platforms, as well as printed 3D cell architectures. Several 3D-bioprinting methods have recently been applied to originate and improve 3D-cell culture. 3D bioprinters allow for the automated creation of repeatable, rapid, and personalised 3D structures. Several businesses are developing devices capable of producing realistic 3D human tissues for medication and treatment research.
3D Bioprinting Market Dynamics
The introduction of novel pathogens has resulted in unforeseen human illnesses and epidemics. The COVID-19 pandemic has highlighted the critical need for a platform to execute quick and agile development of therapies and vaccines to combat emerging viruses such as SARS-CoV-2. To produce safe and effective pharmaceuticals, the standard drug development process normally takes 10-15 years. Modifying the drug discovery pipeline with new advanced technologies such as 3D bioprinting is therefore attracting interest for accelerating drug discovery.
3D Bioprinting Market Regional Insights
The Asia Pacific region dominated the 3D bioprinting market in 2021, with a revenue share of 23.7%; the region is expected to continue its lead across the forecast period. Japan and China accounted for the largest revenue share in the sector due to an increase in COVID-19 cases and higher government R&D investment. China had around 87,706 active COVID-19 cases documented as of January 13th, 2021. Furthermore, a dearth of organ donors and the growing death rate caused by COVID-19 are expected to accelerate the 3D bioprinting sector in this field.
The North American market had a revenue share of 31.8% in 2021, and it is expected to continue to dominate during the forecast period. The market is expected to develop due to the increasing usage of IT in the healthcare sector. The government is increasing its investment in research and development to create a vaccine for this condition. There is a growing demand for 3D bioprinting since it has been recognised for application in drug testing and organ donation.
3D Bioprinting Market Segmentation
By Technology Insights
- Magnetic 3D
- Inkjet 3D
By Deployment Mode
- Extracellular Matrices
- Living cells
- Other Biomaterials
By Application Area
- Tissue and organ generation
- Medical pills
- Prosthetics and implants
- Consumer/Personal Product Testing
- Food and Animal Product
3D Bioprinting Market Key Competitors are:
- EnvisionTEC, Inc.
- Organovo Holdings, Inc.
- Inventia Life Science PTY LTD
- Vivax Bio, LLC
- Cyfuse Biomedical K.K.
- 3D Bioprinting Solutions
- Cellink Global
- Regemat 3D S.L.
- Bico group ab,
- Collplant Biotechnologies Ltd.
- Aspect Biosystems Ltd.
- Advanced Solutions Life Sciences, LLC
- Rokit Healthcare, inc.
- Pandorum Technologies pvt. ltd.
- Foldink Life Science Technologies
- Revotek co., ltd.
- Precise Bio
Key questions answered in the 3D Bioprinting Market are:
- What are the technological innovations in 3D Bioprinting Market?
- What are the factors driving the growth of the 3D Bioprinting Market?
- Which technology insight dominated the 3D Bioprinting Market in 2021?
- How COVID-19 affected the growth of the 3D Bioprinting Market?
- What is the growth rate of the 3D Bioprinting Market during the forecast period?
- What are the trends of the Asia-Pacific region in the 3D Bioprinting Market?
- Who are the market leaders in 3D Bioprinting in North America region?
- Which deployment mode led the 3D Bioprinting Market in 2021?
- Who are the key players in the 3D Bioprinting Market?
- What are the factors restraining the growth of the 3D Bioprinting Market?
- Which region held the largest market share in 3D Bioprinting Market?
- Market Share, Size & Forecast by Revenue | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
- Market Segmentation – A detailed analysis by Technology Insights, Deployment Mode, Application Area, and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Maximize Market Research is leading life science research firm, has also published the following reports:
CRISPR Technology Market: The CRISPR Technology Market is expected to reach USD 5.79 billion by 2029 at a CAGR of 23.5 percent during the forecast period. The CRISPR Technology Market is driven by increasing demand for CRISPR technology acorss the globe.
Label-free Array Systems Market: The Label-free Array Systems Market is expected to reach USD 2.12 billion by 2029 at a CAGR of 7 percent during the forecast period. The Label-free Array Systems Market drivers are developing range of drug discovery projects and growing choice for personalised or precision medicine.
Asthma Treatment Market: The Asthma Treatment Market is expected to reach USD 28.15 billion by 2029 at a CAGR of 4.27 percent during the forecast period. The Asthma Treatment Market growth is expected to be driven by growing occurrence of asthma and regulatory approvals.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
For critical insights on this maTo remain ‘ahead’ of your competitors, request for a sample @ https://www.maximizemarketresearch.com/request-sample/3271
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
Company Name: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact Person: Geeta Yevle
Email: Send Email
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,